8,229 Shares in USANA Health Sciences, Inc. (USNA) Purchased by Laurion Capital Management LP
Laurion Capital Management LP acquired a new position in USANA Health Sciences, Inc. (NYSE:USNA) during the first quarter, Holdings Channel reports. The fund acquired 8,229 shares of the company’s stock, valued at approximately $690,000.
Several other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. grew its position in shares of USANA Health Sciences by 10.7% in the 3rd quarter. Vanguard Group Inc. now owns 1,245,807 shares of the company’s stock worth $150,182,000 after buying an additional 120,709 shares during the last quarter. BlackRock Inc. grew its holdings in shares of USANA Health Sciences by 1.2% during the fourth quarter. BlackRock Inc. now owns 1,089,647 shares of the company’s stock worth $128,283,000 after buying an additional 13,320 shares in the last quarter. MERIAN GLOBAL INVESTORS UK Ltd grew its holdings in shares of USANA Health Sciences by 54.1% during the first quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 363,410 shares of the company’s stock worth $30,479,000 after buying an additional 127,543 shares in the last quarter. Norges Bank purchased a new stake in shares of USANA Health Sciences during the fourth quarter worth $35,531,000. Finally, Robeco Institutional Asset Management B.V. grew its holdings in shares of USANA Health Sciences by 3.4% during the first quarter. Robeco Institutional Asset Management B.V. now owns 246,416 shares of the company’s stock worth $20,665,000 after buying an additional 8,205 shares in the last quarter. 54.69% of the stock is currently owned by hedge funds and other institutional investors.
Shares of USNA stock opened at $73.92 on Friday. The stock has a market cap of $1.77 billion, a PE ratio of 14.33 and a beta of 0.30. USANA Health Sciences, Inc. has a twelve month low of $73.38 and a twelve month high of $137.95.
USNA has been the subject of a number of research reports. Tigress Financial initiated coverage on shares of USANA Health Sciences in a report on Tuesday, April 16th. They set a “buy” rating for the company. ValuEngine lowered shares of USANA Health Sciences from a “hold” rating to a “sell” rating in a report on Wednesday. Finally, Pivotal Research reaffirmed a “buy” rating and set a $105.00 target price on shares of USANA Health Sciences in a report on Wednesday, May 1st.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Featured Story: What is a Fibonacci Channel?
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.